Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Nohra Guy P
Relationship:   Director
City:   San Francisco
State:   CA
   
Insider Summary:
  
   
Companies Owned :   19    
Direct Shares   10,292,949    

Indirect Shares

   31,541,253      
Direct Value   $216,006,790    

Indirect Value

   $223,774,393      
Total Shares   41,834,202      
Total Value   $439,781,183      


Rigel Pharmaceuticals Inc $11,703 Crucell Nv $0 Ellie Mae Inc $151,292,653 Aerie Pharmaceuticals Inc $55,145,510 Evofem Biosciences Inc $1,339,776 aTyr Pharma Inc $651,483 Sutro Biopharma Inc $7,565,665 Bioventus Inc. $0 Rigel Pharmaceuticals Inc $11,703 Crucell Nv $0 Ellie Mae Inc $151,292,653 Aerie Pharmaceuticals Inc $55,145,510 Evofem Biosciences Inc $1,339,776 aTyr Pharma Inc $651,483 Sutro Biopharma Inc $7,565,665 Bioventus Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    2    

     Stock price went up :
    0   
    1    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
 31.9%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            AVADEL Pharmaceuticals Plc AVDL N/A 2003-10-02 0 2003-10-02 6,443    Premium*  
            Rigel Pharmaceuticals Inc RIGL N/A 2004-08-20 9,593 2004-08-20 29,715    Premium*  
            Renovis Inc RNVS Director 2004-02-10 0 2004-02-10 42,240    Premium*  
            Crucell Nv CRXLY N/A 2004-05-25 6,436 2004-05-25 0    Premium*  
            Icagen Inc ICGN 10% Owner 2005-02-08 0 2005-02-08 2,135,003    Premium*  
            Cutera Inc CUTR Director 2005-08-15 0 2005-08-15 0    Premium*  
            Neurogesx Inc NGSX 10% Owner 2007-05-07 0 2007-05-07 1,735,673    Premium*  
            Acelrx Pharmaceuticals Inc ACRX Director 2011-02-16 0 2013-09-20 2,507,974    Premium*  
            Ellie Mae Inc ELLI 10% Owner 2011-04-20 1,528,363 2011-04-20 1,524,804    Premium*  
            Esperion Therapeutics, Inc. ESPR 10% Owner 2013-07-01 0 2014-10-21 2,552,189    Premium*  
            Aerie Pharmaceuticals Inc AERI 10% Owner 2014-05-22 3,616,099 2013-10-30 0    Premium*  
            Trevena Inc TRVN 10% Owner 2014-02-05 0 2014-12-10 4,390,262    Premium*  
            Zs Pharma, Inc. ZSPH Director 2015-12-17 0 2014-06-23 3,230,090    Premium*  
            Evofem Biosciences Inc EVFM Former 10% Owner 2015-12-30 1,339,776 2014-11-25 2,595,257    Premium*  
            Kalvista Pharmaceuticals Inc KALV Director 2015-04-14 0 2015-04-14 4,343,550    Premium*  
            aTyr Pharma Inc LIFE 10% Owner 2015-05-12 1,778,064 2015-05-12 0    Premium*  
            Allakos Inc. ALLK 10% Owner 2021-03-04 0 2021-03-04 6,448,053    Premium*  
            Sutro Biopharma Inc STRO 10% Owner 2018-10-01 1,944,901 2018-10-01 0    Premium*  
            Bioventus Inc. BVS Director 2023-08-16 69,717 2023-08-16 0    Premium*  
* Premium Members only  

Records found :    86         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ACRX Acelrx Pharmaceuticals In... Director   –       •       •   2011-02-16 4 B $5.00 $3,400,000 I/I 680,000 2,794,907 2.25 -
ACRX Acelrx Pharmaceuticals In... Director   –       •       •   2011-02-16 4 A $0.00 $0 I/I 2,114,907 2,114,897 0 -
ACRX Acelrx Pharmaceuticals In... Director   –       •      –    2013-09-16 4 AS $10.75 $176,221 I/I (16,398) 2,778,509 0 -
ACRX Acelrx Pharmaceuticals In... Director   –       •      –    2013-09-17 4 AS $10.48 $523,107 I/I (49,921) 2,728,588 0 -
ACRX Acelrx Pharmaceuticals In... Director   –       •      –    2013-09-18 4 AS $10.29 $642,480 I/I (62,461) 2,666,127 0 -
ACRX Acelrx Pharmaceuticals In... Director   –       •      –    2013-09-19 4 AS $10.21 $629,450 I/I (61,634) 2,604,493 0 -
ACRX Acelrx Pharmaceuticals In... Director   –       •      –    2013-09-20 4 AS $10.84 $1,046,131 I/I (96,519) 2,507,974 0 -
AERI Aerie Pharmaceuticals Inc 10% Owner   –       –       •   2013-10-30 4 B $10.00 $1,100,000 D/D 110,000 3,916,099 2.45 -
AERI Aerie Pharmaceuticals Inc 10% Owner   –       –       •   2013-10-30 4 A $0.00 $0 D/D 3,806,099 3,806,099 0 -
AERI Aerie Pharmaceuticals Inc 10% Owner   –       –       •   2014-05-22 4 S $16.00 $4,800,000 D/D (300,000) 3,616,099 0 -
ALLK Allakos Inc. 10% Owner   –       –       •   2018-07-23 4 B $18.00 $4,500,000 I/I 250,000 11,519,200 1.5 -
ALLK Allakos Inc. 10% Owner   –       –       •   2018-07-23 4 A $0.00 $0 I/I 11,269,200 11,269,200 0 -
ALLK Allakos Inc. 10% Owner   –       –       •   2020-06-17 4 S $75.23 $581,693 D/D (7,692) 0 0 %
ALLK Allakos Inc. 10% Owner   –       –       •   2021-03-04 4 S $108.89 $2,876,742 D/D (25,768) 0 0 %
LIFE aTyr Pharma Inc 10% Owner   –       –       •   2015-05-12 4 A $0.00 $0 D/D 1,778,064 1,778,064 0 -
AVDL AVADEL Pharmaceuticals Pl... See Footnotes   –       –      –    2003-10-02 4 D $33.25 $63,175,000 I/I (1,900,000) 6,443 -
BVS Bioventus Inc. Director   –       •      –    2021-02-11 3/A IO $0.00 $0 I/I 0 2,604,264 -
BVS Bioventus Inc. Director   –       •      –    2022-02-11 4 OE $0.00 $0 D/D 9,000 9,000 0 -
BVS Bioventus Inc. Director   –       •      –    2022-04-01 4 OE $0.00 $0 D/D 2,700 11,700 0 -
BVS Bioventus Inc. Director   –       •      –    2023-06-06 4 OE $0.00 $0 D/D 16,648 28,348 0 -
BVS Bioventus Inc. Director   –       •      –    2023-08-16 4/A D $0.00 $0 I/I (2,604,264) 0 0 -
BVS Bioventus Inc. Director   –       •      –    2023-08-16 4 A $0.00 $0 D/D 41,369 69,717 0 -
CRXLY Crucell Nv See Footnote   –       –      –    2004-04-21 4 A $0.00 $0 I/I 1,668,451 45,854 -
CRXLY Crucell Nv See Footnote   –       –      –    2004-04-22 4 S $8.21 $164,144 I/I (20,000) 45,304 -
CRXLY Crucell Nv See Footnote   –       –      –    2004-04-23 4 S $8.11 $5,045 I/I (622) 45,287 -
  86  Records found
  1  2   3   4      
  Page 1 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us